Mortality and longevity of elite athletes

Journal of Science and Medicine in Sport

Volumn 13, Issue 4, 2010, Pages 410-416

  Teramoto, Masaru ^a   Bungum, Timothy J ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

Death; Endurance; Epidemiology; Exercise training; Power

Indexed keywords

AEROBIC EXERCISE; ANAEROBIC EXERCISE; ATHLETE; CARDIOVASCULAR RISK; CAUSE OF DEATH; ENDURANCE TRAINING; HUMAN; LIFE EXPECTANCY; LONGEVITY; MORTALITY; REVIEW; RISK REDUCTION; SPORT; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; FEMALE; MALE; TRENDS;

ATHLETES; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MORTALITY;

EID: 77953962557     PISSN: 14402440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsams.2009.04.010     Document Type: Review

References (50)

1. Physical Activity Guidelines Advisory Committee Physical activity guidelines advisory committee report, 2008 2008, U.S. Department of Health and Human Services, Washington, DC.
2. Expert Panel on the Identification Evaluation and Treatment of Overweight, Obesity in Adults Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998, 158(17):1855-1867.
3. U.S.Department of Health and Human Services 2008 Physical Activity Guidelines for Americans 2000, U.S. Department of Health and Human Services, Washington, DC.
4. U.S.Department of Health and Human Services Healthy People 2010 2000, vol. II. U.S. Department of Health and Human Services, Washington, DC.
5. Paffenbarger R.S., Lee I.-M. A natural history of athleticism, health and longevity. J Sports Sci 1998, 16(Suppl. 1):S31-S45.
6. Wannamethee S.G., Shaper A.G. Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med 2001, 31(2):101-114.
7. Shaper A.G., Wannamethee G., Walker M. Physical activity, hypertension and risk of heart attack in men without evidence of ischaemic heart disease. J Hum Hypertens 1994, 8(1):3-10.
8. Maron B.J., Poliac L.C., Roberts W.O. Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 1996, 28(2):428-431.
9. Thompson P.D., Franklin B.A., Balady G.J., Blair S.N., Corrado D., Estes N.A.M., et al. Exercise and acute cardiovascular events: placing the risks into perspective. Med Sci Sports Exerc 2007, 39(5):886-897.
10. Sarna S., Sahi T., Koskenvuo M., Kaprio J. Increased life expectancy of world class male athletes. Med Sci Sports Exerc 1993, 25(2):237-244.
11. Åstrand P.-O., Rodahl K. Physical training. Textbook of Work Physiology 1986, McGraw-Hill Book Company, New York. 3rd ed.
12. Coleman A.E. Physiological characteristics of major league baseball players. Phys Sports Med 1982, 10(5):51-57.
13. Maud P.J. Physiological and anthropometric parameters that describe a rugby union team. Br J Sports Med 1983, 17(1):16-23.
14. Wilmore J.H., Haskell W.L. Body composition and endurance capacity of professional football players. J Appl Physiol 1972, 33(5):564-567.
15. Karvonen M.J., Klemola H., Virkajarvi J., Kekkonen A. Longevity of endurance skiers. Med Sci Sports 1974, 6(1):49-51.
16. Taioli E. All causes of mortality in male professional soccer players. Eur J Public Health 2007, 17(6):600-604.
17. Belli S., Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease?. Eur J Epidemiol 2005, 20(3):237-242.
18. Abel E.L., Kruger M.L. Longevity of major league baseball players. Res Sports Med 2005, 13(1):1-5.
19. Abel E.L., Kruger M.L. The healthy worker effect in major league baseball revisited. Res Sports Med 2006, 14(1):83-87.
20. Metropolitan Life Insurance Company Longevity of major league baseball players. Stat Bull Metropol Life Insur Co 1975, 56:2-4.
21. Waterbor J., Cole P., Delzell E., Andjelkovich D. The mortality experience of major-league baseball players. N Engl J Med 1988, 318(19):1278-1280.
22. Armstrong G.L., Conn L.A., Pinner R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281(1):61-66.
23. Cooper R., Cutler J., Desvigne-Nickens P., Fortmann S.P., Friedman L., Havlik R., et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 2000, 102(25):3137-3147.
24. Abel E.L., Kruger M.L. The healthy worker effect in professional football. Res Sports Med 2006, 14(4):239-243.
25. Beaglehole R., Stewart A. The longevity of international rugby players. N Z Med J 1983, 96(735):513-515.
26. Parssinen M., Kujala U., Vartiainen E., Sarna S., Seppala T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med 2000, 21(3):225-227.
27. Gajewski A.K., Poznanska A. Mortality of top athletes, actors and clergy in Poland: 1924-2000 follow-up study of the long term effect of physical activity. Eur J Epidemiol 2008, 23:335-340.
28. Menotti A., Amici E., Gambelli G.C., Milazzotto F., Bellotti P., Capocaccia R., et al. Life expectancy in Italian track and field athletes. Eur J Epidemiol 1990, 6(3):257-260.
29. Schnohr P. Longevity and causes of death in male athletic champions. Lancet 1971, 2(7738):1364-1366.
30. Lee I.M., Skerrett P.J. Physical activity and all-cause mortality: what is the dose-response relation?. Med Sci Sports Exerc 2001, 33(Suppl. 6):S459-S471.
31. Blair S.N., Kohl H.W., Barlow C.E., Paffenbarger R.S., Gibbons L.W., Macera C.A. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995, 273(14):1093-1098.
32. Blair S.N., Kohl H.W., Paffenbarger R.S., Clark D.G., Cooper K.H., Gibbons L.W. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262(17):2395-2401.
33. Williams P.T. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 2001, 33(5):754-761.
34. Frederiksen H., Christensen K. The influence of genetic factors on physical functioning and exercise in second half of life. Scand J Med Sci Sports 2003, 13(1):9-18.
35. Montgomery H., Safari L. Genetic basis of physical fitness. Annu Rev Anthropol 2007, 36:391-405.
36. Fogelholm M., Kaprio J., Sarna S. Healthy lifestyles of former Finnish world class athletes. Med Sci Sports Exerc 1994, 26(2):224-229.
37. Kujala U.M., Sarna S., Kaprio J., Tikkanen H.O., Koskenvuo M. Natural selection to sports, later physical activity habits, and coronary heart disease. Br J Sports Med 2000, 34(6):445-449.
38. Pollock M.L., Franklin B.A., Balady G.J., Chaitman B.L., Fleg J.L., Fletcher B., et al. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000, 101(7):828-833.
39. Williams M.A., Haskell W.L., Ades P.A., Amsterdam E.A., Bittner V., Franklin B.A., et al. Resistance exercise in individuals with and without cardiovascular disease: 2007 update: a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2007, 116(5):572-584.
40. Blair S.N., Cheng Y., Holder J.S. Is physical activity or physical fitness more important in defining health benefits?. Med Sci Sports Exerc 2001, 33(6 Suppl.):S379-S399.
41. Kujala U.M., Kaprio J., Taimela S., Sarna S. Prevalence of diabetes, hypertension, and ischemic heart disease in former elite athletes. Metabolism 1994, 43(10):1255-1260.
42. Miller M.A., Croft L.B., Belanger A.R., Romero-Corral A., Somers V.K., Roberts A.J., et al. Prevalence of metabolic syndrome in retired National Football League players. Am J Cardiol 2008, 101(9):1281-1284.
43. Rogers R.G., Hummer R.A., Krueger P.M. The effect of obesity on overall, circulatory disease- and diabetes-specific mortality. J Biosoc Sci 2003, 35(1):107-129.
44. Livingston E.H., Ko C.Y. Effect of diabetes and hypertension on obesity-related mortality. Surgery 2005, 137(1):16-25.
45. Curry L.A., Wagman D.F. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters. Percept Mot Skills 1999, 88(1):224-233.
46. Thiblin I., Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol 2005, 19(1):27-44.
47. Sjoqvist F., Garle M., Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008, 371(9627):1872-1882.
48. de Groot LCPMG, Verheijden M.W., de Henauw S., Schroll M., van Staveren W.A. Lifestyle, nutritional status, health, and mortality in elderly people across Europe: a review of the longitudinal results of the SENECA study. J Gerontol A: Biol Sci Med Sci 2004, 59(12):1277-1284.
49. Iestra J.A., Kromhout D., van der Schouw Y.T., Grobbee D.E., Boshuizen H.C., van Staveren W.A. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 2005, 112(6):924-934.
50. Cook D.J., Mulrow C.D., Haynes R.B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997, 126(5):376-380.